Lange Louis G
- SEC CIK
- 0001238401
In the past year, 2 open-market sale filings worth $2.19M and no purchases.
Current role at each company
- NAMS NewAmsterdam Pharma Co N.V.Directoras of Mar 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.19M
- 2 filings
- Net
- −$2.19M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lange Louis G as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 (view filing) | Mar 11 | 1 day | Lange Louis GDirector | SSale | −44.6K | $30.42 | −$1.36M | −81.2%10.4K after | 2 lots |
| Mar 10, 2026 (view filing) | Mar 6 | 4 days | Lange Louis GDirector | SSale | −28.2K | $29.41 | −$829.0K | −100.0%0 after | |
| Feb 21, 2024 (view filing) | Feb 13 | 8 daysLate | Lange Louis GDirector | PPurchase | +5.00K | $19.00 | +$95.0K | +25.2%24.9K after |